{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:47:07Z","timestamp":1792698427558,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12028-021-01244-x","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T22:05:49Z","timestamp":1622153149000},"page":"783-788","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Non-Vitamin K Antagonist Oral Anticoagulants for the Treatment of Cerebral Venous Sinus Thrombosis: a Retrospective, Matched Cohort Analysis"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3197-3062","authenticated-orcid":false,"given":"James A.","family":"Giles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamshi K. S.","family":"Balasetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson R.","family":"Zazulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"issue":"17","key":"1244_CR1","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMra042354","volume":"352","author":"J Stam","year":"2005","unstructured":"Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352(17):1791\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"1244_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(07)70029-7","volume":"6","author":"MG Bousser","year":"2007","unstructured":"Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol. 2007;6(2):162\u201370.","journal-title":"Lancet Neurol"},{"issue":"12","key":"1244_CR3","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1161\/STROKEAHA.112.671453","volume":"43","author":"JM Coutinho","year":"2012","unstructured":"Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke. 2012;43(12):3375\u20137.","journal-title":"Stroke"},{"issue":"9","key":"1244_CR4","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1161\/STROKEAHA.116.013617","volume":"47","author":"S Devasagayam","year":"2016","unstructured":"Devasagayam S, Wyatt B, Leyden J, Kleinig T. Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study. Stroke. 2016;47(9):2180\u20132.","journal-title":"Stroke"},{"issue":"4","key":"1244_CR5","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","volume":"42","author":"G Saposnik","year":"2011","unstructured":"Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2011;42(4):1158\u201392.","journal-title":"Stroke"},{"issue":"10","key":"1244_CR6","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/ene.13381","volume":"24","author":"JM Ferro","year":"2017","unstructured":"Ferro JM, Bousser MG, Canhao P, Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis\u2014endorsed by the European Academy of Neurology. Eur J Neurol. 2017;24(10):1203\u201313.","journal-title":"Eur J Neurol"},{"issue":"12","key":"1244_CR7","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1001\/jamaneurol.2019.2764","volume":"76","author":"JM Ferro","year":"2019","unstructured":"Ferro JM, Coutinho JM, Dentali F, Kobayashi A, Alasheev A, Canhao P, et al. Safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial. JAMA Neurol. 2019;76(12):1457\u201365.","journal-title":"JAMA Neurol"},{"issue":"8","key":"1244_CR8","doi-asserted-by":"publisher","first-page":"915.e11","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.02.004","volume":"21","author":"SFK Hon","year":"2012","unstructured":"Hon SFK, Li HLT, Cheng PW. Use of direct thrombin inhibitor for treatment of cerebral venous thrombosis. J Stroke Cerebrovasc Dis. 2012;21(8):915.e11-15.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"7","key":"1244_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/ijs.12462","volume":"10","author":"MD Mendonca","year":"2015","unstructured":"Mendonca MD, Barbosa R, Cruz-e-Silva V, Calado S, Viana-Baptista M. Oral direct thrombin inhibitor as an alternative in the management of cerebral venous thrombosis: a series of 15 patients. Int J Stroke. 2015;10(7):1115\u20138.","journal-title":"Int J Stroke"},{"issue":"8","key":"1244_CR10","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1161\/STROKEAHA.114.006167","volume":"45","author":"C Geisbusch","year":"2014","unstructured":"Geisbusch C, Richter D, Herweh C, Ringleb PA, Nagel S. Novel factor Xa inhibitor for the treatment of cerebral venous and sinus thrombosis: first experience in 7 patients. Stroke. 2014;45(8):2469\u201371.","journal-title":"Stroke"},{"issue":"3","key":"1244_CR11","first-page":"1","volume":"5","author":"S Anticoli","year":"2016","unstructured":"Anticoli S, Pezzella F, Scifoni G, Ferrari C, Pozzessere C. Treatment of cerebral venous thrombosis with rivaroxaban. J Biomedical Sci. 2016;5(3):1\u20132.","journal-title":"J Biomedical Sci"},{"key":"1244_CR12","doi-asserted-by":"crossref","unstructured":"Covut F, Kewan T, Perez O, Flores M, Haddad A, Daw H. Apixaban and rivaroxaban in patients with cerebral venous thrombosis. Thromb Res. 2019;173:77\u201378.","DOI":"10.1016\/j.thromres.2018.11.018"},{"issue":"9","key":"1244_CR13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1302507","volume":"369","author":"G Agnelli","year":"2013","unstructured":"Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013;369(9):799\u2013808.","journal-title":"N Engl J Med"},{"issue":"11","key":"1244_CR14","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1161\/STROKEAHA.110.588822","volume":"41","author":"JM Coutinho","year":"2010","unstructured":"Coutinho JM, Ferro JM, Canhao P, Barinagarrementeria F, Bousser MG, Stam J, et al. Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke. 2010;41(11):2575\u201380.","journal-title":"Stroke"},{"issue":"11","key":"1244_CR15","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981\u201392.","journal-title":"N Engl J Med"},{"key":"1244_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jocn.2017.07.028","volume":"45","author":"S Gazioglu","year":"2017","unstructured":"Gazioglu S, Eyuboglu I, Yildirim A, Aydin CO, Alioglu Z. Cerebral venous sinus thrombosis: clinical features, long-term outcome and recanalization. J Clin Neurosci. 2017;45:248\u201351.","journal-title":"J Clin Neurosci"},{"issue":"2","key":"1244_CR17","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1161\/01.STR.0000112972.09096.65","volume":"35","author":"E Stolz","year":"2004","unstructured":"Stolz E, Trittmacher S, Rahimi A, Gerriets T, Rottger C, Siekmann R, et al. Influence of recanalization on outcome in dural sinus thrombosis: a prospective study. Stroke. 2004;35(2):544\u20137.","journal-title":"Stroke"},{"issue":"2","key":"1244_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","volume":"149","author":"C Kearon","year":"2016","unstructured":"Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: chest guideline and expert panel report. Chest. 2016;149(2):315\u201352.","journal-title":"Chest"},{"issue":"12","key":"1244_CR19","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2019;50(12):e344\u2013418.","journal-title":"Stroke"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-021-01244-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-021-01244-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-021-01244-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T14:08:51Z","timestamp":1640095731000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-021-01244-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1244"],"URL":"https:\/\/doi.org\/10.1007\/s12028-021-01244-x","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]},"assertion":[{"value":"6 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval for this retrospective study was granted by the Washington University School of Medicine Institutional Review Board (Ref. 201905143).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}